Future burden of myocardial infarction in Australia: impact on health outcomes between 2019 and 2038

Author:

Abebe Tamrat Befekadu1ORCID,Morton Jedidiah I12ORCID,Ilomaki Jenni1ORCID,Ademi Zanfina13ORCID

Affiliation:

1. Centre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences, Monash University , Melbourne , Australia

2. Baker Heart and Diabetes Institute , Melbourne , Australia

3. School of Public Health and Preventive Medicine, Monash University , Melbourne , Australia

Abstract

Abstract Background Myocardial infarction (MI) remains a major health burden in Australia. Yet the future burden of MI has not been extensively studied for the Australian population. Methods and results A multistate lifetable model was constructed to estimate the lifetime risk of MI and project the health burden of MI for the Australian population aged between 40 and 100 years over a 20-year period (2019–2038). Data for the model were primarily sourced from the Victorian-linked dataset and supplemented with other national data. The lifetime risk of MI at age 40 was estimated as 24.4% for males and 13.2% for females in 2018. From 2019 to 2038, 891 142 Australians were projected to develop incident MI. By 2038, the model estimated there would be 702 226 people with prevalent MI, 51 262 incident non-fatal MI, and 3717 incident fatal MI; these numbers represent a significant increase compared to the 2019 estimates, with a 27.0% (148 827), 62.0% (19 629), and 104.7% (1901) rise, respectively. Projected years of life lived (YLL) (5% discount) accrued by the Australian population was 174 795 232 (84 356 304 in males and 90 438 928 in females), with 7 657 423 YLL among people with MI (4 997 009 in males and 2 660 414 in females). Conclusion The burden of MI was projected to increase between 2019 and 2038 in Australia. The outcomes of the model provide important information for decision-makers to prioritize population-wide prevention strategies to reduce the burden of MI.

Funder

Monash Graduate Research Scholarship

Monash International Tuition Fee Scholarship

National Health and Medical Research Council

AstraZeneca

Amgen

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Health Policy

Reference47 articles.

1. The top 10 causes of death;WHO

2. Decline in cardiovascular mortality: possible causes and implications;Mensah;Circ Res,2017

3. Explaining the decrease in US deaths from coronary disease, 1980–2000;Ford;N Engl J Med,2007

4. Trends in cardiovascular deaths;AIHW

5. Heart, stroke and vascular disease;AIHW

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3